EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS133-22701 
Organism
Homo sapiens 
Tissue/cell
melanoma 
Coordinate
chr3:101592060-101592900 
Target genes
Number: 9             
NameEnsembl ID
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOXP1MA0481.2chr3:101592621-101592633ATGTAAACAGAA+6.92
FOXP2MA0593.1chr3:101592621-101592632ATGTAAACAGA+6.02
NFAT5MA0606.1chr3:101592518-101592528ATTTTCCATT+6.02
NFATC1MA0624.1chr3:101592518-101592528ATTTTCCATT+6.02
NFATC3MA0625.1chr3:101592518-101592528ATTTTCCATT+6.02
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_09392chr3:101591738-101593533CD14
SE_59234chr3:101526313-101596096Ly3
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr3101592355101592794
chr3101592400101592632
Number: 1             
IDChromosomeStartEnd
GH03I101873chr3101592355101592845
Enhancer Sequence
CTTGTCACTT TGGATTGGCC AAAACTTCAA TGTTCTTCAG CACTGTTTAA TGTCTACAAT 60
TGCTGTTCTG TACTTGTCTC TGCACTAACA CTTCTCTATA CTTACTATAA GACCCGGGTA 120
GTCTTGACAT GGGCACGTGC ACCTTAGCCC TGAGTCAAGA ATTCATAGAG AATCTTCCAT 180
ACAACTTCTG GGACCCACCT TCTCACCACC CCCAAAACAC CTTTCGTTTT GGTGCCTTGC 240
TCTACAGATT CTTCTGAACT CTTATCTCTG CCTTGTCAGC TCAGCAGAAC TACTGTGCTC 300
AGATTGGATT CTAGCTTGCT ATGCTGTGGT TGGAAAATTG TACCCTTGCA GAGATCCAGG 360
ATAATCATGG GCCTCACCTA ATGAATTTCT CCTCTCTCAG AGATCACAGT GTTTAATTTC 420
CTGTTGTCCA ATGCTGAAAA ACAATTGCCT CATATATTAT TTTCCATTTC ATTGTTTATG 480
GGTGGAGAGC TAGTCCTATA CCAGTTGTTT CATCATAGTT GGAAGTGAAA GTTTGCAAGA 540
TGTGTTCTTA AAGATTAAAT TATGTAAACA GAAACGGATT TACCAAAGAG GGGGCCCAAA 600
GATTCTGTTT GGGCTGAAAA AGCATTTATA ATAGTCATGA GTCCCATCCT ATGACTCAGA 660
CACTGACTCC ATTCATAGGA AGTTAGTATA GTGGAGTAGA GTGTAGTTTC TCTGCGTTAT 720
TTCTAAAAAT TGAGTCTAAC AGCCATCTCC CCTCTCTAGG AAACAAAAAG AAGGTTTCTA 780
AAAATAATAG TAGTAATAAT AACTTACTAT TATTATATAC TTAATGTTCT AGGTTCTGTC 840